Recombinant Human CXCL10

Leinco Technologies
Product Code: LEI-I-202
Product Group: Recombinant Proteins
CodeSizePrice
LEI-I-202-10ug10 ug£273.00
Quantity:
LEI-I-202-50ug50 ug£625.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Human
Regulatory Status: RUO
Shipping:
Ambient
Storage:
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.

Further Information

Format:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.4 with no calcium, magnesium, or preservatives.
Formulation:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.4 with no calcium, magnesium, or preservatives.
Long Description:
CXCL10, also known as IP-10 and CRG-2, is a small cytokine belonging to the CXC chemokine family. Binding of this protein to the cell surface chemokine receptor CXCR3, results in pleiotropic effects, including stimulation of monocytes, natural killer and T cell migration and modulation of adhesion molecule expression. CXCL10 is secreted by several cell types in response to IFN-γ including monocytes, endothelial cells and fibroblasts (1). CXCL10 has been attributed to several roles, such as chemoattraction for monocytes/macrophages, T cells, NK cells, and dendritic cells, promotion of T cell adhesion to endothelial cells, antitumor activity and inhibition of bone marrow colony formation and angiogenesis (2-3). Additionally, it is angiostatic and mitogenic for vascular smooth muscle cells. CXCL10 plays a role in the regulation of tubular cell proliferation following renal ischemia-reperfusion injury (4). CXCL10 shows anti-microbial and anti-bacterial activity (5-6).
NCBI Gene:
3627
Purity:
>97% by SDS-PAGE and analyzed by silver stain.
Target:
CXCL1

References

1. Luster, AD. et al.(1985) Nature 315: 672 2. Dufour, JH. et al.(2002) J. Immunol. 168 3. Angiolillo, AL. et al.(1995) J. Exp. Med. 182: 155 4. Kaneko, S. et al.(2008) Nephron Exp. Nephrol. 109:(1):c29-38

Related Products

Product NameProduct CodeSupplier 
Anti-Human CXCL1 (Clone 20326)LEI-C1393Leinco Technologies Summary Details
Anti-Human CXCL1 (Clone 31716)LEI-C1394Leinco Technologies Summary Details
Anti-Mouse CXCL1 (Clone 48415)LEI-C1420Leinco Technologies Summary Details
Rat CINC-1/CXCL1 ELISA Development KitLEI-C1608Leinco Technologies Summary Details
Anti-Human CXCL1/GRO alphaLEI-G118Leinco Technologies Summary Details
Anti-Rat CXCL1LEI-G121Leinco Technologies Summary Details
Recombinant Human CXCL1LEI-G125Leinco Technologies Summary Details
Recombinant Rat CXCL1/KCLEI-G126Leinco Technologies Summary Details
Anti-Rat CXCL1 - BiotinLEI-G144Leinco Technologies Summary Details
Anti-Human CXCL1-BiotinLEI-G145Leinco Technologies Summary Details
Rat CXCL1/CINC-1 ELISA Development KitLEI-G700Leinco Technologies Summary Details
Human GRO alpha/CXCL1 ELISA Development KitLEI-G718Leinco Technologies Summary Details
Recombinant Mouse KC/CXCL1LEI-K114Leinco Technologies Summary Details
Anti-Mouse CXCL1- BiotinLEI-K124Leinco Technologies Summary Details
Anti-Mouse CXCL1LEI-K125Leinco Technologies Summary Details
Anti-Mouse KC-BiotinLEI-K133Leinco Technologies Summary Details
Anti-Mouse CXCL1 (Clone 124014)LEI-K135Leinco Technologies Summary Details